Pharma Mirror

MARCH 17, 2024

Finding the right dentist in Whittier can be daunting, but it’s crucial for maintaining oral health. From routine check-ups to specialized treatments, a reliable dentist can make all the difference. In this article, we’ll walk you through five essential steps to help you find the best dentist in Whittier for your specific needs. So, let’s dive right in!

130

130

Pharma Mirror

JANUARY 19, 2024

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry. The global stage has witnessed significant upheavals throughout 2023, with wars impacting everything from oil prices to work locations.

Life Science 130

Life Science Vaccination Vaccine Research 130

Pharma Mirror

MARCH 11, 2024

Reimagining conventional tube saw design has led to an innovative, cordless model that cuts the widest range of piping and tubing sizes and materials with greater precision, efficiency, and longevity. The pharmaceutical industry requires extensive piping and tubing systems to maintain stringent quality and regulatory standards. These specialized systems are designed to ensure the purity of critical fluids, such as pharmaceutical-grade water, raw materials, active pharmaceutical ingredients (APIs

Production 130

Production 130

Pharma Mirror

FEBRUARY 14, 2024

In the dynamic realm of laboratory instruments, ultra-low freezers play a pivotal role in preserving valuable samples and reagents. These sophisticated devices are crucial for various fields, ranging from medical research to pharmaceutical development. Today, we delve into the nuances of ultra-low (also called so low) freezer repair, exploring their main applications and common troubleshooting issues.

Reagent 130

Reagent Development Research 130

Pharma Mirror

FEBRUARY 6, 2024

By Barbara Arone, Vice President, Real World Solutions, IQVIA The use of real-world evidence (RWE) in the development of pharmaceutical treatments has grown exponentially in the past 10 years, fueled by availability of higher quality data, trial competitiveness and growing investments in personalized and rare disease treatments. It has transformed from a “nice-to-have” into a “must-have” part of the evidence package, helping to contextualize clinical research and improve treatment understanding.

Production 100

Production Packaging Packaging Clinical Research 100

Pharma Mirror

JANUARY 5, 2024

New Delhi, India – FD-AID, LLC, a distinguished leader in pharmaceutical quality and compliance solutions, proudly announces its entry into the Indian pharmaceutical market. Spearheaded by a former US FDA Investigator and seasoned pharmaceutical executive, FD-AID is uniquely positioned to bring a wealth of expertise and insight to India’s rapidly growing pharmaceutical industry.

Compliance 130

Compliance FDA Compliance Marketing Drugs 130

Pharma Mirror

JANUARY 2, 2024

The popularity of at-home DNA testing is soaring in popularity and uses. When someone seeks information about paternity or genetic diseases without visiting a doctor’s chamber or laboratory, the best alternative is the at-home DNA test kit. Unless and until the paternity tests are not for legal cases, at-home test kits are an ideal choice. The question which concerns everyone is, ‘are home DNA test kits accurate?’.

DNA 130

DNA Genetic Disease Genetics 130

Pharma Mirror

NOVEMBER 30, 2023

By Alexei Voloshin, Global Head of Bioprocess Science, 3M Biopharmaceutical Purification Article Synopsis: Modern biotechnology has brought a revolution in improving the human condition around the world both in terms of quantity and quality. The rapid pace of innovation in biopharmaceutical treatments has enabled the treatment of life-threatening and life-changing conditions such as cancer, inflammation, and infectious disease.

Manufacturing 130

Manufacturing 130

Pharma Mirror

OCTOBER 30, 2023

Indonesia, being the fourth most populous country in the world, presents a significant market opportunity for medical device manufacturers. The Indonesia medical device registration process is a necessary pathway for any foreign manufacturer looking to supply their products in this burgeoning market. The growth potential is immense due to the increasing healthcare expenditure and growing awareness about advanced medical technologies among the population.

Manufacturing 130

Manufacturing Marketing Production 130

Pharma Mirror

OCTOBER 16, 2023

Van Nieuwenhove succeeds Mark Egerton, who retires after 18 years in the role Wayne Hewett also joins Quotient Board of Directors as Non-Executive Chairman NOTTINGHAM, UK: Quotient Sciences (“Quotient” or the “Company”), a leading global pharmaceutical drug development and manufacturing accelerator, is pleased to announce the appointment of Thierry Van Nieuwenhove as its new Chief Executive Officer (CEO), effective 16th October 2023.

Manufacturing 130

Manufacturing Development Drugs 130

Pharma Mirror

OCTOBER 16, 2023

by Carrie Taylor, Director of Research & Development of BOCSCI. Globally, the COVID-19 pandemic has significantly accelerated the development of mRNA technology platforms and mRNA industry chains. The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021. mRNA drugs mRNA drugs encode mRNA based on the selection of targets or antigens and enter the cytoplasm through specific delivery systems (such as LN

Immune Response 130

Immune Response Drugs Protein Vaccination 130

Pharma Mirror

SEPTEMBER 8, 2023

Niclosamide is an anthelmintic medication that has been used for decades to treat various types of parasitic infections in humans and animals. Niclosamide works by disrupting the energy metabolism of the parasitic worms, specifically by interfering with their ability to generate adenosine triphosphate (ATP), which is essential for their survival. This disruption ultimately leads to the death of the parasites.

Drugs 130

Drugs Medicine 130

Pharma Mirror

SEPTEMBER 6, 2023

by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why. Compliance with complex laws and regulations, like Direct-to-Consumer Advertising (DTCA) Rules or the Health Insurance Portability and Accountability Act (HIPAA), can be quite daunting.

Life Science 130

Life Science Marketing Compliance Branding 130

Pharma Mirror

SEPTEMBER 1, 2023

San Antonio’s online suboxone clinics serve as lifesavers for individuals fighting opioid addiction. Offering advanced treatments and personalized care, these online clinics light the dark tunnel of addiction recovery. This post delves into how these clinics aid in patients’ transformative journeys. Understanding the Role of Suboxone in Opioid Addiction Treatment Suboxone is a potent weapon in our arsenal against opioid addiction, primarily utilized in Medication-Assisted Treatment (

Drugs 130

Drugs 130

Pharma Mirror

SEPTEMBER 1, 2023

The integration of artificial intelligence (AI) tools across medical communications is proving to be a transformative development, ushering in increased efficiencies and innovation across the healthcare industry. by Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, an Inizio company A subset of AI, augmented intelligence, refers to the synergy between AI, machine learning, and natural language processing (NLP) technologies to complement human intelligence

Development 130

Development 130

Pharma Mirror

SEPTEMBER 1, 2023

North Charleston, SC: Pharmaceutical sterilization and cleaning equipment manufacturer Belimed Life Science, North Charleston, SC, has unveiled custom wash rack design and manufacturing services. A key option offered with the company’s automated cleaning and disinfecting wash systems, the custom wash rack services were developed to help pharmaceutical and nutritional product manufacturers ensure complete cleaning and disinfection of laboratory glassware, tableting tools, containers, valves

Manufacturing 130

Manufacturing Life Science Containment Production 130

Pharma Mirror

JUNE 29, 2023

A bright smile is said to be the best compliment one can hear from others, and the heart of preserving and sweetening those smiles lies in a dentist’s hand. Dentistry, the art, and science of oral health, confines a diverse range of practices and professionals committed to maintaining the well-being of your teeth, gums, and overall oral health.

130

130

Pharma Mirror

JUNE 23, 2023

LAUSANNE, Switzerland – Viseven, a leading global MarTech services provider for the Pharma and Life Sciences industries, is thrilled to announce its partnership with SpotMe, an enterprise event platform tailored to high-touch industries. This collaboration marks a significant milestone in digital communication within the healthcare industry. Driving Success in Pharma Communication The partnership between Viseven and SpotMe creates a unique point of view on the HCP engagement and B2B event organi

Life Science 130

Life Science 130

Pharma Mirror

JUNE 23, 2023

In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs). Two such approaches are through the use of omnichannel and sales enablement technologies, which can revolutionize the way pharmaceutical companies develop their sales force and interact with their stakeholders.

Sales 130

Sales Development Marketing 130

Pharma Mirror

JUNE 15, 2023

In recent years, the field of clinical trials has witnessed a significant transformation due to advancements in technology. The integration of technology into clinical trials has revolutionized the way researchers conduct studies, collect data, and analyze results. This article explores the current trends in clinical trial technology and their impact on the research landscape.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Pharma Mirror

JUNE 16, 2023

The Hague — Plans to develop FIP-UNESCO UNITWIN centres for excellence for pharmacy education across the world have been bolstered by a renewed agreement between the International Pharmaceutical Federation (FIP) and the United Nations Educational, Scientific and Cultural Organization (UNESCO) concerning the UNITWIN Network on Global Pharmacy Education Development, the federation announced today.

Pharmacy 130

Pharmacy Development 130

Pharma Mirror

JUNE 16, 2023

OTTAWA – As a new fiscal year unfolds, the Canadian Dental Hygienists Association (CDHA) celebrates its long-standing partnerships with dental industry. These meaningful collaborations have been instrumental in moving the dental hygiene profession forward and in building awareness across Canada of the importance of oral health and its impact on our overall health.

Development 130

Development 130

Pharma Mirror

JUNE 16, 2023

Maintaining optimal tablet tooling is paramount for achieving effective production outcomes. Inadequate handling and aftercare methods are responsible for 85% of punch and die problems. To address this critical issue, I Holland, leader in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets, has developed Safestore and tool tray racking, an innovative system designed to securely store tooling.

Manufacturing 130

Manufacturing Production Marketing Development 130

Pharma Mirror

MAY 31, 2023

In the face of increasing global health challenges, the development and production of vaccines have become paramount. One critical aspect is the ability to scale up manufacturing processes to meet the growing demand for viral vector-based vaccines. In this article, we will explore the efforts being made by innovative biotechnology companies to develop scalable and cost-effective manufacturing methods.

Vaccination 130

Vaccination Vaccine Manufacturing Production 130

Pharma Mirror

MAY 23, 2023

Davis, California – Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems. QS-21 is used in several innovative vaccines against diseases such as shingles, malaria and RSV, plus promising new vaccine and immunotherapy treatments such as cancer.

Vaccination 130

Vaccination Vaccine Production Marketing 130

Pharma Mirror

JANUARY 26, 2023

by Dodie Guadines, Viseven Regional Director, APAC Region In 2022 the APAC pharmaceutical market was estimated at $40.25 billion. At the same time, Asia-Pacific pharma players expect their businesses to grow rapidly in the upcoming year. With an estimated CAGR of 10.5%, the APAC market is expected to reach a booming $64.96 billion by 2027. Within the region, the Indian market shows impressive success, responsible for 80% of anti-retroviral drugs and 50% of the global supply of vaccines.

Marketing 130

Marketing Vaccination Vaccine Drugs 130

Pharma Mirror

JANUARY 24, 2023

Belgium team to expand under Country Manager, Dr Pierre-Hervé Brun, providing CNS treatments to patients Brussels and Düsseldorf – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the establishment of Neuraxpharm Belgium to cover Belgium and Luxembourg, completing its presence in Benelux as it continues its expansion pathway in Europe.

Branding 130

Branding Marketing Pharmacy 130

Pharma Mirror

JANUARY 24, 2023

Science-based innovation for manufacturing high quality cells challenges dogma and terminology Cell and gene therapies are dominating the world of drug development. With the promise of significant breakthroughs in treatment of diabetes, cancer, and congenital conditions, it is no wonder that research and development is predicted to reach $232.5 billion by 2026, up from $186 billion in 2019 according to the Evaluate Pharma report.

Production 130

Production Gene Therapy Manufacturing Gene 130

Pharma Mirror

JANUARY 23, 2023

The White House Office of Science & Technology Policy (OSTP) convened a listening session January 11. This webinar focused on the need for a coordinated clinical trials enterprise, one that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.

Clinical Trials 147

Clinical Trials Clinical Trials Trials Clinical Research 147

Pharma Mirror

JANUARY 1, 2023

by Dr Torill Bigg, Chief Carbon Reduction Engineer at Tunley Engineering Businesses globally are looking to reduce their carbon footprints. A number of factors is driving this activity. It is a smart and ethical business practice to operate sustainably for the environment and for grand success. Demonstrating environment leadership enhances business reputation, retains and attracts customers, investors, and staff – and enhances market value.

Engineer 130

Engineer Marketing 130

Pharma Mirror

DECEMBER 1, 2022

QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications. Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has entered into a Partnership Agreement with Croda Pharma to build a robust, scalable and truly sustainable supply chain and deliver kilogram-quantities of QS-21 to the pharmaceutical in

Production 130

Production Vaccination Vaccine 130

Pharma Mirror

NOVEMBER 29, 2022

As AI technology advances, it is quickly finding its way into the world of healthcare. The rise of machine learning and chatbots in healthcare is moving away from the traditionally doctor-centric model and towards a more patient-centric and automated process built on trust and data. Healthcare is one of the few industries that’s heavily regulated.

Doctors 130

Doctors Doctor Regulation 130

Pharma Mirror

OCTOBER 17, 2022

What is AI? Artificial intelligence (AI) is intelligence demonstrated by machines, as opposed to the natural intelligence displayed by animals including humans. AI research has been defined as the field of study of intelligent agents, which refers to any system that perceives its environment and takes actions that maximize its chance of achieving its goals.

Sales 130

Sales Marketing Research 130

Pharma Mirror

OCTOBER 17, 2022

BRISBANE, AUS, AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new senior executive hires to support global growth plans. International biopharma executive Guillaume Herry has been appointed as CEO, while HR executive Joanne Reichardt has been appointed Head of People & Culture.

HR 130

HR Protein Vaccination Vaccine 130

Pharma Mirror

OCTOBER 13, 2022

TOKYO / HAMBURG, Olympus Corporation (Olympus), a global medtech company committed to making lives healthier, safer and more fulfilling, has announced the launch of the EU-ME3, a new Endoscopic Ultrasound Processor which addresses the needs of healthcare professionals for high-quality clear images while conducting endoscopic ultrasound procedures. The EU-ME3 will be available in Europe, the Middle East, Africa, parts of Asia, and Oceania within this fiscal year.

130

130

Pharma Mirror

OCTOBER 5, 2022

INCHEON, South Korea, Samsung Biologics (KRX: 207940.KS), a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms – S-DUAL™ and DEVELOPICK™ – at this year’s BioProcess International Conference and Exhibition in Boston. S-DUAL™ is a high-yield bispecific antibody platform with a 99% chain-pairing success rate.

Development 130

Development Manufacturing Antibody 130

Pharma Mirror

OCTOBER 1, 2022

Nanjing (China) and Barcelona (Spain), a global biopharmaceutical company focused on skin health, and Simcere Pharmaceutical Group（2096.HK), an innovation and R&D-driven pharmaceutical company; today announced that they have entered into an exclusive licensing agreement for Simcere’s IL-2 mutant fusion protein (IL-2 mu-Fc) autoimmune drug candidate, SIM0278.

Licensing 130

Licensing Licensing Protein Development 130